Tecan Group AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0012100191
CHF
126.40
-2.3 (-1.79%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 9.50%

  • The company has been able to generate a Return on Equity (avg) of 9.50% signifying low profitability per unit of shareholders funds
2

Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 9.50%

 
3

Flat results in Jun 25

4

With ROE of 1.80%, it has a Very Expensive valuation with a 1.46 Price to Book Value

5

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CHF 1,740 Million ()

stock-summary
P/E

81.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.21%

stock-summary
Debt Equity

-0.11

stock-summary
Return on Equity

1.80%

stock-summary
Price to Book

1.36

Revenue and Profits:
Net Sales:
110 Million
(Quarterly Results - Dec 2006)
Net Profit:
14 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.92%
0%
-18.92%
6 Months
-26.3%
0%
-26.3%
1 Year
-39.11%
0%
-39.11%
2 Years
-60.52%
0%
-60.52%
3 Years
-69.7%
0%
-69.7%
4 Years
-76.46%
0%
-76.46%
5 Years
-68.74%
0%
-68.74%

Tecan Group AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
6.86%
EBIT Growth (5y)
-4.56%
EBIT to Interest (avg)
66.56
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0.71
Tax Ratio
13.56%
Dividend Payout Ratio
56.60%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.44%
ROE (avg)
9.50%
Valuation key factors
Factor
Value
P/E Ratio
81
Industry P/E
Price to Book Value
1.46
EV to EBIT
64.56
EV to EBITDA
64.56
EV to Capital Employed
1.52
EV to Sales
8.42
PEG Ratio
NA
Dividend Yield
2.06%
ROCE (Latest)
2.35%
ROE (Latest)
1.80%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'06 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2006 is 1.94% vs 0.00% in Dec 2005",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2006 is 89.47% vs 0.00% in Dec 2005",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'06",
        "Dec'05",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "110.40",
          "val2": "108.30",
          "chgp": "1.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.80",
          "val2": "11.90",
          "chgp": "32.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "14.40",
          "val2": "7.60",
          "chgp": "89.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "143.50%",
          "val2": "109.60%",
          "chgp": "3.39%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -6.11% vs 20.89% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is 9.08% vs -0.49% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,074.40",
          "val2": "1,144.30",
          "chgp": "-6.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "201.70",
          "val2": "213.00",
          "chgp": "-5.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "1.30",
          "chgp": "-23.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "4.80",
          "val2": "-2.50",
          "chgp": "292.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "132.10",
          "val2": "121.10",
          "chgp": "9.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "121.80%",
          "val2": "127.60%",
          "chgp": "-0.58%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'06 - YoYstock-summary
Dec'06
Dec'05
Change(%)
Net Sales
110.40
108.30
1.94%
Operating Profit (PBDIT) excl Other Income
15.80
11.90
32.77%
Interest
1.20
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
14.40
7.60
89.47%
Operating Profit Margin (Excl OI)
143.50%
109.60%
3.39%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2006 is 1.94% vs 0.00% in Dec 2005

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2006 is 89.47% vs 0.00% in Dec 2005

Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
1,074.40
1,144.30
-6.11%
Operating Profit (PBDIT) excl Other Income
201.70
213.00
-5.31%
Interest
1.00
1.30
-23.08%
Exceptional Items
4.80
-2.50
292.00%
Consolidate Net Profit
132.10
121.10
9.08%
Operating Profit Margin (Excl OI)
121.80%
127.60%
-0.58%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is -6.11% vs 20.89% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is 9.08% vs -0.49% in Dec 2022

stock-summaryCompany CV
About Tecan Group AG stock-summary
stock-summary
Tecan Group AG
Pharmaceuticals & Biotechnology
Tecan Group AG is a Switzerland-based company engaged in the development, production and distribution of advanced automation and detection solutions for the life science laboratories. Its product portfolio is diversified into several product groups. The Liquid Handling & Robotics group encompasses laboratory technologies for safety, among others. The Reader & Washer product group covers micro plate instruments. The Microarray Products group includes microarray scanner and automated hybridization station. The HP D300 Digital Dispenser and Sample Management product groups cover systems for automated management of sample libraries. The Components group covers the supply services of products for laboratory automation instruments. The OEM (original equipment manufacturing) product group covers platform-based systems, systems from scratch and Cavro OEM Components. The Company also offers packaged software and consumables through Software and Consumables product groups, respectively.
Company Coordinates stock-summary
Company Details
Seestrasse 103 , MAENNEDORF None : 8708
stock-summary
Tel: 41 44 922811141 44 9228430
stock-summary
Registrar Details